Reference
Quek AML, et al. Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis (MS): Real world experience from Singapore. Multiple Sclerosis Journal 25: 463-464 abstr. P-56, No. 3, 2019. Available from: URL: http://doi.org/10.1177/1352458519826874 [abstract] - Singapore
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1748, 36 (2019). https://doi.org/10.1007/s40278-019-59952-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59952-9